MENU
+Compare
MMIRF
Stock ticker: OTC
AS OF
Dec 19 closing price
Price
$0.05
Change
+$0.02 (+66.67%)
Capitalization
38.45M

MMIRF Medmira Inc. Forecast, Technical & Fundamental Analysis

MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies... Show more

MMIRF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MMIRF with price predictions
Dec 23, 2025

Momentum Indicator for MMIRF turns positive, indicating new upward trend

MMIRF saw its Momentum Indicator move above the 0 level on December 02, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 70 similar instances where the indicator turned positive. In of the 70 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MMIRF just turned positive on December 03, 2025. Looking at past instances where MMIRF's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

MMIRF moved above its 50-day moving average on December 19, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for MMIRF moved below the 200-day moving average on December 08, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

MMIRF broke above its upper Bollinger Band on December 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MMIRF entered a downward trend on December 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (26.864). P/E Ratio (0.000) is within average values for comparable stocks, (51.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.882). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (200.000) is also within normal values, averaging (312.120).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MMIRF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MMIRF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
MMIRF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
155 Chain Lake Drive
Phone
+1 902 450-1588
Employees
65
Web
https://www.medmira.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATRRF112.69N/A
N/A
Altarea Paris
NVYTF0.51N/A
N/A
Novacyt Clamart
SNNUF15.85N/A
N/A
Smith & Nephew PLC
CLOW0.02N/A
N/A
Cloudweb, Inc.
PSGFF0.26N/A
N/A
Precious Shipping Plc

MMIRF and Stocks

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
-0.47%
AZTR - MMIRF
24%
Poorly correlated
-2.11%
SRPT - MMIRF
22%
Poorly correlated
+3.63%
SLS - MMIRF
21%
Poorly correlated
+4.92%
More